BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20455467)

  • 1. [CD4+ and CD8+ T-lymphocyte counts in human immunodeficiency virus type 1 subtype A-infected patients carrying mutations V77I in protease and/or A62V in reverse transcriptase].
    Selimova LM; Serebrovskaia LV; Ivanova LA; Nosik DN
    Vopr Virusol; 2010; 55(2):22-6. PubMed ID: 20455467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of T-cell immunity to antiretroviral drug-resistant human immunodeficiency virus type 1.
    Stratov I; Dale CJ; Chea S; McCluskey J; Kent SJ
    J Virol; 2005 Jun; 79(12):7728-37. PubMed ID: 15919925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protease and reverse transcriptase genetic polymorphism in HIV type 1 subtype A variants predominating in cis countries].
    Sukhanova AL; Bogoslovskaia EV; Kruglova AI; Bashkirova LIu; Tsyganova GM; Shipulin GA; Kazennova EV; Alikina IuI; Zverev SIa; Grishechkin AE; Pokrovskiĭ VV; Bobkova MR; Bobkov AF
    Mol Biol (Mosk); 2005; 39(6):1063-71. PubMed ID: 16358744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the reverse transcriptase and protease genes of human immunodeficiency virus-1 from antiretroviral naïve and treated pediatric patients.
    Bure D; Makhdoomi MA; Lodha R; Prakash SS; Kumar R; Parray HA; Singh R; Kabra SK; Luthra K
    Viruses; 2015 Feb; 7(2):590-603. PubMed ID: 25674767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy.
    Machado ES; Lambert JS; Watson DC; Afonso AO; da Cunha SM; Nogueira SA; Caride E; Oliveira RH; Sill AM; DeVico A; Tanuri A
    J Clin Virol; 2004 May; 30(1):24-31. PubMed ID: 15072750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo.
    Kieffer TL; Kwon P; Nettles RE; Han Y; Ray SC; Siliciano RF
    J Virol; 2005 Feb; 79(3):1975-80. PubMed ID: 15650227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes.
    Zaunders JJ; Geczy AF; Dyer WB; McIntyre LB; Cooley MA; Ashton LJ; Raynes-Greenow CH; Learmont J; Cooper DA; Sullivan JS
    AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1519-27. PubMed ID: 10580402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
    Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
    Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India.
    Arora SK; Gupta S; Toor JS; Singla A
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):125-30. PubMed ID: 18240959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
    Dyrhol-Riise AM; Voltersvik P; Røsok BI; Olofsson J; Asjö B
    AIDS Res Hum Retroviruses; 2000 Feb; 16(3):191-201. PubMed ID: 10710207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns among treatment-naive patients in different stages of infection in Rio de Janeiro, Brazil.
    Varella RB; Ferreira SB; de Castro MB; Zalis MG; Tavares MD
    J Med Virol; 2007 Aug; 79(8):1033-9. PubMed ID: 17596836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological recovery despite virological failure is independent of human immunodeficiency virus-type 1 resistant mutants in children receiving highly active antiretroviral therapy.
    Chiappini E; Galli L; Zazzi M; de Martino M
    J Med Virol; 2003 Aug; 70(4):506-12. PubMed ID: 12794711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of evidence for protease evolution in HIV-1-infected patients after 2 years of successful highly active antiretroviral therapy.
    Parera M; Ibañez A; Clotet B; Martinez MA
    J Infect Dis; 2004 Apr; 189(8):1444-51. PubMed ID: 15073682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.
    Pariente N; Pernas M; de la Rosa R; Gómez-Mariano G; Fernández G; Rubio A; López M; Benito JM; López-Galíndez C; Leal M; Domingo E; Martinez MA; Mas A
    J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses.
    Lichtenstein KA; Armon C; Nagabhushanam V; Efaw BJ; Frazer-Abel A; Hiserote ME; Alam R
    Antivir Ther; 2012; 17(7):1301-9. PubMed ID: 22948290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained appearance of drug resistance-associated mutations in HIV-1 CRF01_AE protease and reverse transcriptase derived from protease inhibitor-naive Thai patients.
    Jullaksorn D; Boonchawalit S; Uttiyoung J; Soonthornsata B; Yowang A; Krathong N; Chautrakul S; Ikuta K; Roobsoong A; Kanitvittaya S; Sawanpanyalert P; Kameoka M
    Southeast Asian J Trop Med Public Health; 2010 Mar; 41(2):347-57. PubMed ID: 20578518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T cells from HIV-1-infected patients recognize wild-type and mutant human immunodeficiency virus-1 protease epitopes.
    Muller NG; Alencar R; Jamal L; Hammer J; Sidney J; Sette A; Brindeiro RM; Kalil J; Cunha-Neto E; Moraes SL
    Clin Exp Immunol; 2011 Apr; 164(1):90-9. PubMed ID: 21352200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of HIV type 1 drug resistance among naive patients from Venezuela.
    Castillo J; Comegna M; Quijada W; Jauvin V; Pinson P; Masquelier B; Fleury H; Castro E
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1329-33. PubMed ID: 19954301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal analysis of lymphocyte ratios and HIV-1 intracellular DNA levels in children.
    Saitoh A; Powell CA; Fenton T; Douglas SD; Starr SE; Fletcher CV; Spector SA
    J Infect Dis; 2004 Apr; 189(7):1216-20. PubMed ID: 15031790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.